返回
A
Alain Sibille
Universite Paris Saclay
26H指数
243论文数
2.9K被引数
收录论文 17
发表时间
BMS-986012 (anti-fucosyl-monosialoganglioside-1 [fuc-GM1]) with carboplatin plus etoposide plus nivolumab (CE/NIVO) as first-line (1L) therapy in extensive-stage small cell lung cancer (ES-SCLC): Interim analysis (IA) of a randomized phase II studyBMS-986012(抗岩藻糖基单唾液酸神经节苷脂-1[fuc-GM1])联合卡铂、依托泊苷和纳武利尤单抗(CE/NIVO)作为广泛期小细胞肺癌(ES-SCLC)的一线(1L)疗法:一项随机Ⅱ期研究的期中分析(IA)
ANNALS OF ONCOLOGY
IF65.4

